Zion Market Research has published a new report titled “Male Infertility Treatment Market by Techniques (DNA fragmentation, Oxidative stress analysis, Sperm penetration, Microscopic analysis, Sperm agglutination and Others) – Global Industry Perspective, Comprehensive Analysis, and Forecast, 2014 – 2022”. According to the report, the global male infertility treatment market accounted for USD 248.3 million in 2016 and is expected to reach USD 334.6 by 2022, growing at a CAGR of around 5.1% between 2017 and 2022.
According to Word Health Organization, ‘Infertility is the inability of a sexually active, non-contraception couple to achieve pregnancy in one year’. About 15% of couples do not achieve pregnancy within 1year and seeking for infertility medical treatment. Less than 5% of world population is unwillingly childless. Approximately 90% of male infertility cases are seen mainly due to low sperm counts, and poor sperm quality. The remaining cases of male infertility can be caused by a number of factors including anatomical problems, hormonal imbalances, and genetic defects.
Browse the full report at https://www.zionmarketresearch.com/report/male-infertility-treatment-techniques-market
Male infertility treatment market is driven mainly by increasing incidence of male infertility cases across the different part of the world. For instance, According to the WHO, 1 in every 4 couples in developing countries is expected to be affected by infertility. Moreover, the couples who are not able to have a child are failed to opt for the expensive treatment options for fulfilling their desires which lead to the growth of male infertility market. In addition, torpid lifestyle, increasing age and various environmental and psychological effects are the factors which are directly responsible for increasing growth of male infertility market. However, due to emotional shock and discontinuation of treatment is the key limitation which directly affects the growth of male infertility treatment market. Nonetheless, low-cost treatment and continuous ongoing research and development in the healthcare sector are expected to open growth avenues for the market over the years.
Based on techniques, the global market for male infertility treatment is bifurcated into five types: DNA fragmentation, Oxidative stress analysis, Sperm penetration, Microscopic analysis, Sperm agglutination and others. DNA fragmentation dominated the male infertility treatment market. The growth of this technique is attributed due to its highest accuracy followed by others.
In terms of geography, North America was the leading region for male fertility treatment market in 2016 in terms of revenue due to the availability of technologically advanced computer-guided screening tests. Furthermore, lifestyle-related factors such as smoking, stress, obesity become very common in U.S. and European countries. Moreover, male fertility treatment market has the huge opportunity in emerging market like Asia Pacific, Latin America due to the public awareness, increase disposable income, government initiatives and healthcare infrastructure.
Key players of male infertility treatment market included in the report are ASKA Pharmaceutical Co. Ltd, ZydusCadila Healthcare Limited, Access Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Pantarhei Bioscience B, Cordex Pharma, Inc., Merck Serono, Halotech DNA SL, SCSA Diagnostics, Andrology Solutions.